申联生物20CM三连板！

Core Viewpoint - Shenlian Bio (688098.SH) has experienced a significant stock price increase, reaching a new high since March 2021, with a price of 15.4 yuan and a third consecutive day of a 20% limit up [1] Group 1: Stock Performance - The stock has hit a 20% limit up for three consecutive days, indicating strong market interest and investor confidence [1] - The current stock price of 15.4 yuan marks the highest level since March 2021 [1] Group 2: Company Operations - Shenlian Bio announced that there are no undisclosed significant matters as of the announcement date, confirming normal production and operations [1] - The company’s main business focuses on veterinary biological products, while its innovative drug pipeline, including AIDS monoclonal antibodies, is independently operated by its joint venture, Yangzhou Shizhiyuan Biotechnology Co., Ltd. [1] - The innovative drug business is characterized by long R&D cycles, high investment, and significant research risks [1]